| |
DAY 1 - Sunday, 29 January 2012 |
|
|
15:00 |
Registration |
|
|
18:00 |
Dinner |
|
|
|
|
|
|
|
Grand Opportunities
for MRI-Based Cell Tracking |
|
|
|
Moderators:
Anna Moore, Ph.D. & Erik M. Shapiro, Ph.D. |
|
|
19:00 |
Neural Stem
Cell-Mediated Brain Tumor Treatment Phase I Clinical Trial:
The High Value of MRI Cell Tracking |
Karen S. Aboody,
M.D.
City of Hope Cancer Center
Duarte, CA, USA
|
|
19:30 |
Potential
Therapies with Adult Stem/Progenitor Cells & the Therapeutic
Proteins They Produce
-
permission withheld |
Darwin J.
Prockop, M.D, Ph.D.
Texas A&M University
Temple, TX, USA |
|
20:00 |
Coffee & Desert |
|
|
20:30 |
Optimizing
Immune Cell Therapies with Imaging |
Christopher H.
Contag, Ph.D.
Stanford University School of Medicine
Stanford, CA, USA |
|
21:00 |
Hepatocyte
Transplantation & the Need to Track Engrafted Cells |
Ira J. Fox, M.D.
Children’s Hospital of Pittsburgh
Pittsburgh, PA, USA |
|
21:30 |
Adjournment |
|
|
| |
DAY 2 – Monday, 30 January 2012 |
|
|
07:00 |
Breakfast & Registration |
|
|
09:00 |
Welcome |
Erik M. Shapiro,
Ph.D.
Yale University School of Medicine
New Haven, CT, USA |
|
09:15 |
Poster Teasers |
Erik M. Shapiro,
Ph.D.
Yale University School of Medicine
New Haven, CT, USA |
|
|
|
|
|
|
Session 1:
Tools of the Trade:
Magnetic Particles |
|
|
|
Moderator:
Willem M. Mulder, Ph.D. |
|
|
10:00 |
Is Iron-Oxide
the Best We Can Do? |
Gary Zabow, Ph.D.
National Institutes of Health
Bethesda, MD, USA |
|
10:30 |
Next Generation
Magnetic Particles for Clinical MRI-Based Cell Tracking |
Erik M. Shapiro,
Ph.D.
Yale University School of Medicine
New Haven, CT, USA |
|
11:00 |
Magnetic
Particles: The R&D Perspective from a Pharmaceutical Company |
Claire Corot,
Ph.D.
Guerbet Research
Roissy CDG, France |
|
|
Open Oral
Session 1: Proffered Papers |
|
|
11:30 |
Photothermal
Microscopy as a New Imaging Tool for Visualizing the
Sub-Cellular Localization of Iron Oxide Nanoparticles
|
Steve Williams, Ph.D.
University of Manchester
Manchester, England, UK
|
|
11:45 |
Bacterial
Labeling for In Vivo Detection by MRI
- permission
withheld |
Verena Hoerr,
Ph.D.
University Hospital of Muenster
Muenster, Germany
|
|
12:00 |
Lunch |
|
|
|
|
|
|
|
Session 2:
Designer Jeans or Reporter Genes: Do Either Work? |
|
|
|
Moderator:
Glenn A. Walter, Ph.D. |
|
|
13:30 |
Evolution of
CEST Reporter Genes: Moving Away from the Water |
Assaf A. Gilad,
Ph.D.
Johns Hopkins University
Baltimore, MD, USA |
|
14:00 |
Engineered
Ferritins as Probeless MRI Reporters
- permission
withheld |
Eric T. Ahrens,
Ph.D.
Carnegie Mellon University
Pittsburgh, PA, USA |
|
14:30 |
MRI Reporter
Genes for Imaging Mouse Brain Development |
Daniel H.
Turnbull, Ph.D.
New York University School of Medicine
New York, NY, USA |
|
|
Open Oral
Session 2: Proffered Papers |
|
|
15:00 |
MRI Tracking of
Graft Survival in the Infarcted Heart: Iron Oxide Particles
vs. Ferritin Overexpression Approach |
Anna V. Naumova,
Ph.D.
University of Washington
Seattle, WA, USA |
|
15:15 |
Glioma Cells
Transfected with the Gene mms6 Produce Strong Increase in
Transverse Relaxivity In Vitro
|
Xiaoyong Zhang,
Ph.D.
Emory University
Atlanta, GA, USA |
|
15:30 |
Break |
|
|
|
|
|
|
|
Session 3:
Hitting the Target: Cells as Diagnostic Contrast Agents |
|
|
Moderator:
Jeff W. M. Bulte, Ph.D. |
|
|
16:00 |
MR Imaging of
Macrophages in Tumors & Stem Cell Transplants |
Heike Daldrup-Link,
M.D., Ph.D.
Stanford University
Stanford, CA, USA |
|
16:30 |
The Labeling &
Tracking of Immune Cells used for Cancer Therapy: Findings
with Various Cell Types & Iron Nanoparticles |
Paula J. Foster,
Ph.D.
Robarts Research Institute
London, ON, Canada |
|
17:00 |
Exploiting
Immune Cells to Make Diagnostic Contrast Agents for MRI |
Ali S. Arbab, M.D., Ph.D.
Henry Ford Health System
Detroit, MI, USA |
|
|
Open Oral
Session 3: Proffered Papers |
|
|
17:30 |
MRI-Monitored
Intra-Arterial Delivery of SPIO-Labeled Natural Killer Cells
to Hepatocellular Carcinoma |
Alexander Sheu,
B.Sc.
Northwestern University
Chicago, IL, USA |
|
17:45 |
Specific
Chemotaxis of Magnetically Labeled Mesenchymal Stem Cells:
Implications for MRI of Glioma |
Margaret F.
Bennewitz, M.Sc.
Yale University School of Medicine
New Haven, CT, USA |
|
18:00 |
Poster Session 1 &
Social Hour |
|
|
|
|
DAY 3 – Tuesday, 31 January 2012 |
|
|
07:00 |
Breakfast &
Registration |
|
|
|
|
|
| |
Session 4:
Keeping it Real: Translation to Realistic Pre-Clinical Models |
|
|
Moderator:
Michael T. McMahon, Ph.D. |
|
|
09:00 |
Imaging of
Labeled Pancreatic Islets in Transplantation
- permission
withheld |
Anna Moore,
Ph.D.
Harvard Medical School
Charlestown, MA, USA |
|
09:30 |
Stem Cell Based
Regeneration after Stroke: Contributions of Molecular
Imaging
-
permission withheld |
Dirk Wiedermann,
Ph.D.
Max-Planck-Institut
Köln, Germany |
|
10:00 |
Iron-Oxide
Particles as MRI Contrast Agents for Tracking Immune
Responses |
Chien Ho, Ph.D.
Carnegie Mellon University
Pittsburgh, PA, USA |
|
|
Open Oral
Session 4: Proffered Papers |
|
|
10:30 |
Susceptibility
Weighted MRI for Detection & Quantification of CD34+ Stem
Cells In Vitro &
In Vivo |
Adam D. Waldman,
M.D., Ph.D.
Imperial College, Charing Cross Hospital
London, England, UK |
|
10:45 |
Tracking of
Human Mesenchymal Stem Cells in Association with Stroke
Utilizing 1H & 23Na Nuclei at 21.1 T
|
Jens T.
Rosenberg, Ph.D.
National High Magnetic Field Laboratory
Tallahassee, FL, USA |
|
11:00 |
Brunch/Lunch |
|
|
|
|
|
|
Session 5: Ironing Out Cellular MRI: Alternatives to Magnetite for Cell Tracking |
|
|
Moderator:
Eric T. Ahrens, Ph.D. |
|
|
15:00 |
Fluorine MRI/MRS:
Basic & Clinical Translational Opportunities
|
Samuel A.
Wickline, M.D.
Washington University
St. Louis, MO, USA |
|
15:30 |
Cell Labeling &
Tracking with Paramagnetic Gd2O3 Nanoparticles:
Possibilities & Limitations |
Marc-André
Fortin, Ph.D.
Université Laval
Québec City, Québec, Canada |
|
16:00 |
In Vitro
& In Vivo Studies of Gadonanotube-Labeled Cells |
Lon J. Wilson,
Ph.D.
Rice University
Houston, TX, USA |
|
|
Open Oral
Session 5: Proffered Papers |
|
|
16:30 |
In Vivo
MRI to Track & Quantify Immune Therapeutic Cells using
Paramagnetic Nanoparticles |
Claire Billotey, Ph.D.
Hôpital Edouard Herriot
Lyon, France |
|
16:45 |
In-Vivo
MRI Detection of Fluorine Labeled Stem Cells in a Roden
Model of Acute Myocardial Infarction |
Lowri E. Cochlin,
D.Phil, M.Chem.
University of Oxford
Oxford, England, UK |
|
17:00 |
Poster Session 2 &
Social Hour |
|
|
18:30 |
Reception |
|
|
|
|
DAY 4 –
Wednesday, 1 February 2012 |
|
|
07:00 |
Breakfast & Registration |
|
|
|
|
|
|
|
Session 6:
Seeing is Believing:
Detection Methods & Quantification Techniques |
|
|
Moderator:
Paula J. Foster, Ph.D. |
|
|
09:00 |
Detection
Limits, Quantification & New Contrast Mechanisms |
Brian K. Rutt, Ph.D.
Stanford University
Stanford, CA, USA |
|
09:30 |
MR Imaging of
Short T2/T2* Tissues & Fluids Using Clinical Systems |
Graeme M. Bydder,
M.B., Ch.B.
University of California, San Diego Medical Center
San Diego, CA, USA |
|
10:00 |
Quantitative
Evaluation of Reporter Gene & Particle-Based Labeling
Methods for MR Imaging of Endogenous Neural Stem Cell
Progeny Migration in the Rodent Brain
- permission withheld |
Greetje Vande
Velde, Ph.D.
KULeuven
Leuven, Belgium |
|
|
Open Oral
Session 6: Proffered Papers |
|
|
10:30 |
Assessing Brain
Metastases due to Melanoma using Balanced Steady State Free
Precession & Gadolinium Enhanced MRI
|
Mariama Henry,
B.Sc.
Roberts Research Institute
London, ON, Canada |
|
10:45 |
Texture Analysis
& Cellular Imaging for Characterizing Tumour Proliferation
Patterns |
Lisa M.
Gazdzinski, Ph.D.
University of Toronto
Toronto, ON, Canada |
|
11:00 |
Lunch |
|
|
|
|
|
|
|
Session 7:
The Big Picture: Clinical Utilization |
|
|
|
Moderator:
Alan P. Koretsky, Ph.D. |
|
|
12:00 |
Clinical MRI
Cell-Tracking: The First 7 Years |
Jeff W. M. Bulte,
Ph.D.
Johns Hopkins University
Baltimore, MD, USA |
|
12:30 |
Translational
Molecular Imaging Experiences |
Willem M. Mulder, Ph.D.
Mount Sinai School of Medicine
New York, NY, USA |
|
13:00 |
Round Table
Discussion: Clinic Utility & Translation
Eric T. Ahrens, Ph.D., Jeff W. M. Bulte, Ph.D., Rex A. Moats, Ph.D.
& Willem M. Mulder, Ph.D. |
|
14:00 |
Adjournment |
|
| |
|
|